The U.S. Preventative Services Task Force (USPSTF) has posted its research plan for the screening of the U.S. population for celiac disease. The research plan is designed to answer seven key questions about screening. These questions are: What is the effectiveness of screening versus not screening for celiac disease in asymptomatic adults, adolescents, or […]
Celiac disease remains one of the most common autoimmune diseases, affecting approximately 1% of the population in the United States. Celiac disease is genetic; having a first degree relative with it means you are about ten times more likely to develop the disease. However, almost one third of the U.S. population has the genetic components […]
On August 5th, 2013, the FDA issued its final ruling on the label “gluten-free” and when it could be applied to packaged foods under the FDA’s purview. The compliance date for this ruling, August 5th, 2014, has come and gone, and two studies have been published that investigated the level of gluten in foods labeled […]
Currently, the primary treatment for celiac disease (CD) is a strict and lifelong gluten-free diet, which can saddle patients with heavy financial and social burdens. On top of this, many patients continue to get exposed to gluten accidentally, preventing their intestines from healing properly. Other forms of treatment, such as Alvine Pharmaceutical’s ALV003, are being […]
In the past, celiac disease (CD) was thought of as a children’s malabsorptive disease, but CD patients can experience many non-gastrointestinal symptoms, and a recent paper from Italy attempted to review how CD can affect the reproductive health of women.
The risk for certain types of malignancy in celiac disease (CD) patients has long been a cause for concern. Other types of cancers, such as breast cancer and lung cancer, may be less common in subjects with CD. Studies in the US and UK have pegged the overall increase in risk for malignancy at about […]
A recent study out of Finland investigated how a gluten-free diet, the treatment for CD, helps these asymptomatic patients who have no symptoms to tell them if their treatment is working.
The University of Chicago Celiac Disease Center has been investigating the mechanisms through which viral infections, in particular gastrointestinal viruses, can contribute to the inflammatory response occurring in celiac disease.
After diagnosis, celiac disease (CD) patients must get regular check ups to see if they are responding to their gluten-free diet. Up to 20% of patients have non-responsive celiac disease (NRCD), typically due to accidental gluten exposure. To see if a patient is recovering from CD the doctor can look for any lessening in symptoms, […]
While the prevalence of celiac disease is estimated to be about 1% in the United States, the number of people who have adopted a gluten-free diet is far greater, as shown by the rapidly expanding gluten-free market. For those people who feel better on a gluten-free diet but have tested negative for celiac disease and […]